Rubromycin

• CAT Number: I035801
• CAS Number: 1393-16-4
• Molecular Formula: C27H20O12
• Molecular Weight: 536.44
• Purity: 98%
• Synonyms: Tuoromycin
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: methyl 7,8-dihydroxy-6-[2-(8-hydroxy-5,7-dimethoxy-4,9-dioxobenzo[f][1]benzofuran-2-yl)ethyl]-1-oxoisochromene-3-carboxylate
• InChI: InChI=1S/C27H20O12/c1-35-14-9-15(36-2)22(30)19-18(14)21(29)13-8-12(38-25(13)24(19)32)5-4-10-6-11-7-16(26(33)37-3)39-27(34)17(11)23(31)20(10)28/h6-9,28,30-31H,4-5H2,1-3H3
• InChIKey: LQNGOIZVRFNQLO-UHFFFAOYSA-N
• SMILES: COC1=CC(=C(C2=C1C(=O)C3=C(C2=O)OC(=C3)CCC4=C(C(=C5C(=C4)C=C(OC5=O)C(=O)OC)O)O)O)OC

Rubromycin(CAT: I035801) is a naturally derived antibiotic and potent inhibitor commonly used in cancer and microbial research. It targets DNA and RNA synthesis through its unique ability to inhibit topoisomerase II, making it an invaluable tool for exploring cell cycle regulation and mechanisms of genotoxicity. Rubromycin’s antifungal and antitumor properties enable comprehensive studies on microbial resistance and cancer cell proliferation. With high purity and robust activity, it is ideal for in vitro and in vivo experiments. Rubromycin supports advanced drug discovery efforts and contributes to the development of novel therapies targeting resistant microbial strains and malignancies.